Due to health issues, this site is no longer maintained and will be shut down shortly. |
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.
$1.77 +0.01 (0.28%)
As of 03/27/2023 11:05:12 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.